Lequin M H, van der Shuis I M, Van Rijn R R, Hop W C J, van ven Huevel-Eibrink M M, MuinckKeizer-Schrama S M P F, van Kuijk C
Department of Pediatric Radiology, Sophia Children's Hospital, Rotterdam, The Netherlands.
J Clin Densitom. 2002 Summer;5(2):167-73. doi: 10.1385/jcd:5:2:167.
Acute lymphoblastic leukemia (ALL) in childhood is a serious disease that can affect growth and the attainment of maximal peak bone mass. The latter has recently been recognized as a risk factor for the development of osteoporosis later in life. To determine long-term effects of the disease itself and its treatment, we assessed the bone status of a group of long-term survivors of childhood ALL, all treated with high doses of steroids (dexamethasone) and methotrexate and without cranial irradiation. All 21 subjects enrolled in this cross-sectional study were diagnosed to have non-high-risk precursors acute lymphoblastic leukemia (12 boys and 9 girls, mean age 16.5 yr, range 12.2-25.4 yr). Standard deviation (SD) scores were calculated using a tibial ultrasound device and spinal dual-energy X-ray absorptiometry (DXA) device as bone assessment techniques. SD scores of those two different bone assessment techniques were compared. The mean SOS (speed of sound) SD scores (SDS) of the tibia (mean 0.26, standard deviation [sd] 1.00) were not significantly different from our reference value of 0. There was no significant difference between the SOS SDS in boys and girls. With DXA, no significant difference was seen between the mean BMD SDS and the reference data and no significant difference in BMD between boys and girls was found. The individual mean SDS for bone mineral density (BMD) of lumbar spine are 0.24 (sd 1.02), total body 0.17 (sd 1.00), and apparent BMD (BMAD) 0.07 (sd 1.09). Spearman's correlation between mean SOS SDS and mean BMD of lumbar spine was 0.47, mean SOS SDS and mean BMAD SDS was 0.43, and mean SOS SDS and mean BMD of total body was 0.49. These correlations were significant at the 0.05 level (two tailed). Despite high-dose dexamethasone and methotrexate used for treatment of these children with ALL, no long-term side effects on the bone mineral status of the subjects, measured with DXA or tibial ultrasonometry, could be determined.
儿童急性淋巴细胞白血病(ALL)是一种严重疾病,会影响生长及最大峰值骨量的获得。后者最近被认为是日后发生骨质疏松的一个风险因素。为了确定该疾病本身及其治疗的长期影响,我们评估了一组童年ALL长期幸存者的骨骼状况,他们均接受了高剂量类固醇(地塞米松)和甲氨蝶呤治疗,且未进行颅脑照射。参与这项横断面研究的所有21名受试者均被诊断为非高危前驱急性淋巴细胞白血病(12名男孩和9名女孩,平均年龄16.5岁,范围12.2 - 25.4岁)。使用胫骨超声设备和脊柱双能X线吸收法(DXA)设备作为骨骼评估技术来计算标准差(SD)分数。比较了这两种不同骨骼评估技术的SD分数。胫骨的平均声速(SOS)SD分数(SDS)(平均值0.26,标准差[sd]1.00)与我们的参考值0无显著差异。男孩和女孩的SOS SDS之间无显著差异。采用DXA时,平均骨密度SDS与参考数据之间无显著差异,且男孩和女孩之间的骨密度也无显著差异。腰椎骨矿物质密度(BMD)的个体平均SDS为0.24(sd 1.02),全身为0.17(sd 1.00),表观骨密度(BMAD)为0.07(sd 1.09)。腰椎平均SOS SDS与平均BMD之间的Spearman相关性为0.47,平均SOS SDS与平均BMAD SDS之间为0.43,平均SOS SDS与全身平均BMD之间为0.49。这些相关性在0.05水平(双侧)具有显著性。尽管对这些ALL患儿使用了高剂量地塞米松和甲氨蝶呤进行治疗,但通过DXA或胫骨超声测量,未发现对受试者骨矿物质状况有长期副作用。